Mesangial proliferative glomerulonephritis: Difference between revisions
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 17: | Line 17: | ||
{{CMG}} | {{CMG}} | ||
==[[ | ==[[Mesangial proliferative glomerulonephritis overview|Overview]]== | ||
==[[Mesangial proliferative glomerulonephritis historical perspective|Historical Perspective]]== | ==[[Mesangial proliferative glomerulonephritis historical perspective|Historical Perspective]]== | ||
| Line 40: | Line 40: | ||
==Treatment== | ==Treatment== | ||
[[Mesangial proliferative glomerulonephritis medical therapy|Medical Therapy | [[Mesangial proliferative glomerulonephritis medical therapy|Medical Therapy]] | [[Mesangial proliferative glomerulonephritis secondary prevention|Secondary Prevention]] | [[Mesangial proliferative glomerulonephritis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Mesangial proliferative glomerulonephritis future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[Mesangial proliferative glomerulonephritis case study one|Case #1]] | [[Mesangial proliferative glomerulonephritis case study one|Case #1]] | ||
==References== | ==References== | ||
Latest revision as of 17:09, 27 September 2012
| Mesangial proliferative glomerulonephritis | |
| ICD-10 | N00.3-N08.3 |
|---|---|
| DiseasesDB | 31877 |
|
Mesangial proliferative glomerulonephritis Microchapters |
|
Differentiating Mesangial proliferative glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mesangial proliferative glomerulonephritis On the Web |
|
American Roentgen Ray Society Images of Mesangial proliferative glomerulonephritis |
|
Directions to Hospitals Treating Mesangial proliferative glomerulonephritis |
|
Risk calculators and risk factors for Mesangial proliferative glomerulonephritis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Mesangial proliferative glomerulonephritis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies